Demorphin Raw Powder

Dermorphin raw hmoovyog ib qho tshwm sim ntawm heptapeptide keeb kwm raug cais tawm ntawm daim tawv nqaij ntawm qee yam South American ntoo qav. Nws ua raws li kev xaiv μ- opioid receptor (MOR) agonist thiab tau txais kev txaus siab ntau vim nws cov qauv sib txawv, muaj zog receptor-binding affinity, thiab kuj siab metabolic stability. Hauv nws daim ntawv nyoos hmoov, dermorphin tau siv dav hauv kev tshawb fawb ntawm opioid receptor muaj nuj nqi, kev mob kev taw qhia, thiab nrhiav pom cov tshuaj kho tshiab. Tsis tas li ntawd, nws muab cov txheej txheem molecular muaj txiaj ntsig rau kev tshawb nrhiav kev tsis ncaj ncees agonism thiab tsim cov tshuaj opioid-raws li kev siv tshuaj tua kab mob uas txhim kho kev ua tau zoo thaum txo cov kev tsis zoo.Yog tias koj xav paub ntxiv, hu rau Xi'an Sonwu Biotech Co., Ltd.

Xi'an Sonwu Biotech Co., Ltd yog peptide raw khoom muag nrog peptide thev naus laus zis ntawm nws cov tub ntxhais thiab kev lag luam thoob ntiaj teb kev taw qhia. Sonwu tau mob siab rau R & D, tsim khoom, thiab thoob ntiaj teb kev faib tawm ntawm bioactive peptide thiab polypeptide cov khoom xyaw. Sonwu cov khoom lag luam tau siv dav hauv ntau qhov chaw, suav nrog cov leeg tsim, kev zoo nkauj thiab tiv thaiv - laus, plaub hau noj qab haus huv, tswj qhov hnyav, nootropics, thiab cov khoom siv tshuaj.

Sonwu cov khoom ua haujlwm rau cov neeg siv khoom thoob ntiaj teb, txhawb nqa kev tshawb fawb thiab kev tsim kho thiab kev lag luam. Raws li qhov no, Sonwu tau txais kev tawm tswv yim ntau ntawm Sonwu cov khoom. Yog li ntawd, yog tias koj xav tau demorphin, thov hu rau Xi'an Sonwu.

Xi'an Sonwu tsis tsuas yog muab cov kev pabcuam loj - teev ntau lawm tab sis kuj tseem tuaj yeem muab cov qauv pob khoom rau cov neeg siv khoom ua ntej.

Xi'an Sonwu tsis tsuas yog muab cov khoom siv siab -demorphin zoo, tab sis kuj tuaj yeem kho cov khoom raws li cov neeg siv khoom xav tau. Tsis tas li ntawd, Sonwu tuaj yeem muab cov kev pabcuam ntim khoom, suav nrog cov khoom ntim rov qab raws li cov neeg siv khoom xav tau.

1. Customized fwj (loj, xim, khoom, style)

2. Customized ntim (nqus foil ntim, thawv, nruas)

3. Customized daim ntawv lo (xim zaj duab xis, matte zaj duab xis, kho qhov muag daim npog qhov ncauj)

Dermorphinhmoov nplejtau tshaj tawm thawj zaug hauv xyoo 1981 tom qab kev sib cais thiab tus cwj pwm ntawm peptide los ntawm daim tawv nqaij secretions ntawm South American ntoo qav Phyllomedusa sauvagei. Cov peptide muaj cov amino acid ib ntus Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂ thiab sawv cev rau ib qho ntawm qhov ntxov tshaj plaws tshwm sim opioid peptides amphiians raug txheeb xyuas. Ntau qhov kev tshawb pom uas tshwm sim los ntawm cov kev tshawb fawb tom ntej tau pab tsim nws qhov tseem ceeb hauv opioid pharmacology thiab kev tshawb fawb peptide:

Discovery ntawm ib qho txawv D-Amino Acid Structure: Lub xub ntiag ntawm D-alanine (D-}Ala) ntawm qhov thib ob ntawm qhov sib lawv liag tau cim lub ntsiab lus tseem ceeb hauv nws txoj kev loj hlob. Tsis zoo li L-amino acids uas feem ntau pom nyob rau hauv cov kab mob lom, qhov kev hloov pauv ntawm cov qauv no hloov qhov sib txawv ntawm cov saw peptide; qhov no tsis tsuas yog txhim kho nws txoj kev sib raug zoo rau μ- receptors tab sis kuj ua rau cov peptide tiv thaiv kev degradation los ntawm aminopeptidases, yog li daws kev lag luam - cov kev sib tw dav cuam tshuam nrog ntuj peptides -npe, lawv cov metabolism sai thiab lub sijhawm luv ntawm kev ua.

2. Elucidation of Receptor Selectivity Mechanisms: SAR kev txheeb xyuas qhia tias peptide's N-terminal sequence, Tyr-D-Ala-Phe-Gly, yog qhov tseem ceeb rau μ-opioid receptor binding, 7} minteral, Tyr-Pro-Ser-NH₂, txhim kho receptor subtype selectivity. Ua ke, cov qauv tsim no ua rau muaj μ-receptor affinity uas tshaj qhov ntawd rau δ- lossis κ- receptors los ntawm ntau tshaj peb qhov kev txiav txim ntawm qhov loj, tso dermorphin ua ib qho ntawm feem ntau xaiv natural opioid peptides paub.

3. Tsim kom muaj Synthetic Technology Platform: Ntuj dermorphin tuaj yeem sau tau me me los ntawm cov khoom siv roj ntsha, yog li kev rho tawm ncaj qha tseem kim thiab siv tsis tau. Txhawm rau txhim kho qhov kev tsis sib haum xeeb no, cov pab pawg tshawb fawb feem ntau tig mus rau cov khoom siv -theem peptide synthesis (SPPS) txhawm rau txhim kho cov khoom tso tawm dhau los ntawm cov khoom siv me me. Cov neeg tsim tawm kuj tweak cov qauv peptide thiab tsim nws rau hauv acetate lossis trifluoroacetate ntsev; Cov qauv kev hloov kho no txhim kho nws cov dej solubility thiab txee ruaj khov. Ua tsaug rau cov kev ua kom zoo li no, cov khoom siv peptide tiav yog qhov yooj yim dua rau qhov chaw rau kev kuaj sim thiab cuam tshuam txog kev txhim kho kev ua haujlwm.

Kev tsim khoom ntawmdtshuaj ermorphinrawv powdernruj me ntsis raws li cov qauv nruj, nyob rau hauv lub hauv paus ntawm solid-theem peptide synthesis, siab -kev ua kom huv si, thiab kev ua aseptic. Tag nrho cov haujlwm ua haujlwm tau raug tswj xyuas kom zoo los tswj cov qib impurity thiab xyuas kom muaj kev ncaj ncees. Cov theem tseem ceeb ntawm kev tsim khoom yog raws li nram no:

1. Raw Material Preparation: High-purity amino acid monomers raug xaiv, nrog D-alanine ua cov khoom tseem ceeb, tshwj xeeb raw khoom. Chiral daws cov tswv yim yog ua hauj lwm los xyuas kom meej kho qhov muag purity, yog li tiv thaiv L-isomer impurities los ntawm kev cuam tshuam receptor selectivity.

2.Solid-Phase Synthesis: Cov neeg tsim khoom ua cov synthesis siv Rink amide resin raws li tus qauv Fmoc-raws li cov khoom siv-theem peptide cov txheej txheem. Cov kws kho mob pub rau hauv ib tus neeg cov amino acids thaum saib xyuas txhua kauj ruam sib txuas. Tag nrho qhov chaw tsim khoom tseem tsis muaj menyuam, nrog kev tswj hwm, qis qis oxygen uas ua tau zoo tiv thaiv oxidation -induced breakdown ntawm lengthening peptide qaum.

3. Cleavage thiab Deprotection: Peptide cleavage thiab deprotection yog nqa tawm siv trifluoroacetic acid (TFA). Tom qab cleavage, cov crude peptide yog sau los ntawm qis-tej dej nag thiab centrifugation. Kev tswj xyuas qhov kub ua haujlwm tsawg pab txo qis qhov tsis xav tau degradation thiab kev hloov pauv hauv cov peptide.

4. Purification thiab Refinement: Purification yog ua los ntawm Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). Ib qho acetonitrile-theem dej mobile yog ua haujlwm rau gradient elution kom tshem tawm cov impurities, thiab cov ntsiab lus ntawm lub ncov yog sau los xyuas kom meej qhov tseeb purity ntawm ntau dua los yog sib npaug rau 99%.

1. Ultra-siab receptor selectivity: Nws muaj peev xwm precisely lub hom phiaj ib tug tib receptor subtype, zam tsis yog - tej yam tshwm sim los ntawm receptor activation, ua rau nws yog ib tug zoo tagnrho cov cuab yeej rau kev kawm ywj siab receptor functions.

2. Kev sib xyaw ua kom muaj zog thiab ruaj khov: Hauv qee tus qauv txha caj qaum analgesia, nws cov haujlwm tuaj yeem ncav cuag ntau pua zaus ntawm morphine; Nyob rau tib lub sijhawm, nws qhia tau hais tias muaj zog tiv thaiv enzymatic degradation, thiab nws nyob rau hauv vivo ib nrab - lub neej yog ntev dua li ntawm cov peptides ntuj, txo qhov cuam tshuam ntawm kev sim hloov pauv.

3. Cov qauv -kev sib raug zoo: Kev sib raug zoo ntawm cov qauv molecular thiab receptor khi kev ua haujlwm tau ua tiav tag nrho, muab cov qauv rau kev hloov kho thiab tsim cov receptor ligands tshiab, pab txhim kho cov neeg tsis ncaj ncees agonists, thiab muab kev pom zoo rau kev tsim cov tshuaj qis -side-.

4. Muaj peev xwm txhim kho cov tshuaj zoo: Cov dej solubility zoo heev, tuaj yeem hla cov ntshav - lub paj hlwb teeb meem (nyob rau hauv qee hom tshuaj noj), thiab muaj peev xwm ua rau muaj kev cuam tshuam rau hauv nruab nrab thiab peripheral; nws tuaj yeem ua rau muaj kev txhim kho qis - cov tshuaj muaj txiaj ntsig zoo.

1. Xi'an Sonwu Biotech Co., Ltd. Ltd tau tsim ib qho kev ua tiav technology platform npog peptide molecular tsim, kev cai synthesis, precision purification, kev txheeb xyuas cov qauv, thiab kev tswj kom zoo. Ua raws li cov qauv kev tswj hwm thoob ntiaj teb zoo, lub tuam txhab xyuas kom meej tias nws cov khoom siv peptide ua tau raws li qib siab - cov khoom siv raw khoom kawg ntawm cov neeg siv khoom txawv teb chaws hais txog purity, stability, thiab batch sib xws.

2. Saib mus rau yav tom ntej, Sonwu yuav txuas ntxiv ua kom tob peptide thev naus laus zis tshiab, nthuav dav Sonwu txoj kev koom tes thoob ntiaj teb, thiab sib zog ua kom muaj kev ntseeg siab ntev ntev -lub sij hawm peptide raw khoom tov tus khub rau cov neeg siv khoom thoob ntiaj teb.

Dhau li lav cov khoom, qhov tseem ceeb tshaj plaws yog cov neeg siv khoom tau txais cov khoom lag luam zoo. Yog li, Xi'an Sonwu muaj ntau yam ntawm cov neeg xa xov tuaj yeem ua tau raws li qhov xav tau sib txawv.

Raws li cov ntaub ntawv muab los ntawm kev sim tsiaj thiab kev tshawb fawb daim ntawv thov- thiab saib nruj me ntsis los ntawm qhov kev xav ntawm kev pheej hmoo es tsis yog qhov kev pheej hmoo kho mob - cov kev mob tshwm sim muaj peev xwm tau piav qhia hauv qab no:

1. Receptor-Txog Cov Teeb Meem: Muaj peev xwm ua kom muaj zog ntawm μ-receptors tuaj yeem, ntawm cov koob tshuaj ntau, ua rau muaj kev cuam tshuam xws li sedation, thermoregulatory dysfunction, thiab inhibition ntawm gastrointestinal motility; Cov teebmeem no muaj feem cuam tshuam nrog kev faib tawm ntawm μ-receptors nyob rau hauv ob qho tib si hauv nruab nrab thiab peripheral paj hlwb.

2. Neuromodulatory Risks: Ntev ntev los yog siab tshaj - koob tshuaj yuav ua rau receptor desensitization thiab internalization, yog li cuam tshuam qhov ruaj khov ntawm receptor signaling pathways thiab muaj feem cuam tshuam cov txiaj ntsig ntawm kev sim tshuaj xyuas qhov mob.

3. Kev Nyab Xeeb thiab Kev Tswj Xyuas: Kev cia khoom yuav tsum muaj - qhov kub thiab txias thiab tiv thaiv lub teeb; Cov txheej txheem nruj yuav tsum tau ua raws li kev tshaj tawm thiab tuav cov khoom kom tsis txhob siv tsis raug. Tsis tas li ntawd, opioid receptor antagonists (piv txwv li, naloxone) yuav tsum tau khaws cia yooj yim nyob rau hauv kev sim los daws qhov xwm txheej tshwm sim.

4. Tsis Muaj Kev Kho Mob Tib Neeg - Cov Ntaub Ntawv Zoo: Tsis muaj cov ntaub ntawv hais txog kev mob tshwm sim hauv tib neeg qhov chaw kho mob tam sim no.

Yog tias koj xav nrhiav tus neeg muag khoom ntawm dermorphin, hu rau Xi'an Sonwu. Nyem rau email, thiab tom qab ntawd koj tau txais - cov khoom zoo.

Email:sales02@sonwu.com

Cim npe nrov: Tuam Tshoj demorphin raw hmoov manufacturers, lwm tus neeg, Hoobkas